Target Markets Position inveox as a disruptive automation and digitization partner for pathology laboratories seeking to reduce misdiagnosis risk and increase throughput, targeting hospital networks, cancer centers, and reference pathology labs that require scalable automation and data integration.

Automation+Safety Highlight the core value proposition of automated sample preparation to improve safety, consistency, and traceability in histopathology workflows, presenting ROI through reduced operational irregularities and faster turnaround times.

Cloud+Tech Leverage the existing tech stack and cloud capabilities to propose integrated digital pathology solutions, data analytics, and interoperability with LIS/EMR systems for streamlined lab operations and remote monitoring.

Early Funding Capitalize on strong early-stage funding and notable awards to support outreach with credibility, targeting venture-backed diagnostics companies and private equity groups looking for innovative lab automation assets.

Strategic Partnerships Explore collaboration opportunities with large players in the diagnostic ecosystem (e.g., Roche, Siemens Healthineers, Thermo Fisher) for joint pilots, distribution, or co-development of scalable automation modules and cloud-enabled workflows.